Fibroblast activating protein inhibitor (FAPI) PET/CT imaging may be a non-invasive modality to monitor IgA nephropathy (IgAN) progression, preliminary study results suggest.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback